HIMS
Hims & Hers Health, Inc.
There isn't enough reported data to score HIMS yet.
SLGL
Sol-Gel Technologies Ltd.
There isn't enough reported data to score SLGL yet.
HIMS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Stable | |
| Strong |
HIMS's revenue and balance sheet are currently strong, and its cash flow is stable, but its profitability is weak.
SLGL Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Weak | |
| Stable | |
| Strong |
SLGL's balance sheet is currently strong, and its cash flow is stable, but its revenue and profitability are weak.
HIMS PE Valuation
HIMS has no meaningful PE right now: it lost money over the past year.
SLGL PE Valuation
SLGL has no meaningful PE right now: it lost money over the past year.
HIMS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect HIMS's revenue to grow, but its earnings to decline. However, they disagree widely on these estimates.
SLGL Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong decline | |
| -- | |
| Limited | |
| High |
Analysts expect SLGL's losses to grow, with revenue declining.
HIMS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.83 | -257% |
| Q2 2026 | -$0.63 | -180% |
| Q1 2026 | -$0.09 | -113% |
| Q4 2025 | $0.51 | -3.8% |
| Q3 2025 | $0.53 | +20% |
| Q2 2025 | $0.79 | +888% |
| Q1 2025 | $0.68 | +$0.69 |
| Q4 2024 | $0.53 | +$0.64 |
HIMS has the edge over SLGL on earnings, with more consistent year-over-year improvement.
SLGL Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$5.64 | -$4.38 |
| Q4 2023 | -$10.10 | -$3.64 |
| Q3 2023 | -$10.90 | -765% |
| Q2 2023 | -$10.30 | -379% |
| Q1 2023 | -$8.16 | -3500% |
| Q4 2022 | -$6.46 | -869% |
| Q3 2022 | $1.64 | +$9.20 |
| Q2 2022 | $3.69 | +$15.49 |
SLGL is still losing money, but far less than before: $5.64 per share over the past year, against $15.60 at its worst in late 2019.
HIMS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $890.4M | +49% |
| Q2 2026 | $753.2M | +38% |
| Q1 2026 | $608.1M | +3.8% |
| Q4 2025 | $617.8M | +28% |
| Q3 2025 | $599M | +49% |
| Q2 2025 | $544.8M | +73% |
| Q1 2025 | $586M | +111% |
| Q4 2024 | $481.1M | +95% |
HIMS has the edge over SLGL on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -7.4% | -9.4 points |
| Q2 2026 | -13% | -18 points |
| Q1 2026 | -13% | -23 points |
| Q4 2025 | 1.5% | -2.4 points |
| Q3 2025 | 2% | -3.6 points |
| Q2 2025 | 4.9% | +1.4 points |
| Q1 2025 | 9.9% | +6.3 points |
| Q4 2024 | 3.9% | +4 points |
HIMS has the edge over SLGL on profitability, with a higher operating margin.
SLGL Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $591K | -97% |
| Q1 2026 | $108K | -90% |
| Q4 2025 | $696K | +150% |
| Q3 2025 | $400K | -93% |
| Q2 2025 | $17.3M | +218% |
| Q1 2025 | $1M | +121% |
| Q4 2024 | $278K | -38% |
| Q3 2024 | $5.4M | +2417% |
SLGL's revenue has slid since its 2021 peak: $591,000 last quarter, down 97% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -704% | -769 points |
| Q1 2026 | -3569% | -2690 points |
| Q4 2025 | -490% | +1704 points |
| Q3 2025 | -1572% | -1557 points |
| Q2 2025 | 65% | +35 points |
| Q1 2025 | -880% | -2320 points |
| Q4 2024 | -2194% | -984 points |
| Q3 2024 | -15% | +2946 points |
SLGL's operating margin was −704% last quarter, down 769 points from the same quarter a year ago.
HIMS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $26M | -67% |
| Q2 2026 | -$68.2M | +$1.3M |
| Q1 2026 | $53.1M | +5.9% |
| Q3 2025 | $79.3M | -7% |
| Q2 2025 | -$69.5M | -230% |
| Q1 2025 | $50.1M | +94% |
| Q3 2024 | $85.3M | +238% |
| Q2 2024 | $53.6M | +219% |
SLGL has the stronger cash trend. Its trailing FCF is up 100% versus its history, compared with HIMS at down 84%.
SLGL Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2024 | $0 | $0 |
| Q1 2024 | $0 | $0 |
| Q4 2023 | $0 | $0 |
| Q3 2023 | $0 | $0 |
| Q2 2023 | $0 | $0 |
| Q1 2023 | $0 | $0 |
| Q4 2022 | $0 | +$15.8M |
| Q3 2022 | $0 | $0 |
SLGL's free cash flow was $0 over the past year, against $0 the year before.
HIMS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.9% | +2.1M shares |
| 1 year | -6% | -14.9M shares |
| 3 years | +11% | +23.7M shares |
| 5 years | +17% | +33.8M shares |
HIMS has the edge over SLGL on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | $80.5M |
| Q3 2025 | $9.5M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $5M |
| Q3 2024 | $30M |
| Q2 2024 | $19.9M |
| Q1 2024 | $28.1M |
SLGL Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +15% | +434K shares |
| 1 year | +17% | +485K shares |
| 3 years | +41% | +958K shares |
| 5 years | +42% | +970K shares |
| Available history | +65% | +1.3M shares |
SLGL has 3M diluted shares, up 17% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
HIMS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | -5.9x | Net Cash |
| Q4 2025 | -1.4x | Net Cash |
| Q3 2025 | -2.2x | Net Cash |
| Q2 2025 | -7.3x | Net Cash |
| Q1 2025 | -2.1x | Net Cash |
| Q4 2024 | -2.8x | Net Cash |
| Q3 2024 | -2.9x | Net Cash |
| Q2 2024 | -5.5x | Net Cash |
HIMS has more cash than debt.
SLGL Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2024 | -10.4x | Net Cash |
| Q3 2024 | -4.8x | Net Cash |
| Q3 2022 | -1.6x | Net Cash |
| Q2 2022 | -0.5x | Net Cash |
| Q1 2022 | -9.2x | Net Cash |
| Q4 2021 | -4.8x | Net Cash |
SLGL has more cash than debt.
HIMS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.0 | Neutral |
| Stochastic | 23.0 | Neutral |
HIMS's weekly RSI is 36 (neutral) and its Stochastic is 23 (neutral).
SLGL Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.7 | Neutral |
| Stochastic | 15.5 | Oversold |
SLGL's weekly RSI is 39 (neutral) and its Stochastic is 16 (oversold).
HIMS PE vs Healthcare Sector
| Metric | HIMS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
HIMS has no meaningful PE right now: it lost money over the past year.
SLGL PE vs Healthcare Sector
| Metric | SLGL | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
SLGL has no meaningful PE right now: it lost money over the past year.
HIMS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.3 | 28% below |
| 20 week MA | $29.2 | 32% below |
| 50 week MA | $27.7 | 29% below |
| 100 week MA | $35.9 | 45% below |
| 200 week MA | $24.4 | 19% below |
HIMS is in a downtrend: it's below all five of its weekly moving averages, and 19% below its 200-week average.
SLGL Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $66.2 | 15% below |
| 20 week MA | $72.0 | 22% below |
| 50 week MA | $69.9 | 20% below |
| 100 week MA | $42.6 | 32% above |
| 200 week MA | $30.7 | 83% above |
SLGL has the edge over HIMS on trend strength, trading above more of its moving averages.
HIMS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.89 | $15.0 | +51% |
| 2021 | $15.0 | $6.65 | -56% |
| 2022 | $6.65 | $6.43 | -3.3% |
| 2023 | $6.43 | $8.90 | +38% |
| 2024 | $8.90 | $26.6 | +198% |
| 2025 | $26.6 | $34.3 | +29% |
| 2026 YTD | $34.3 | $19.7 | -42% |
HIMS's yearly returns have swung widely, from +198% in 2024 to −56% in 2021. It's down 42% so far in 2026.
SLGL Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $92.3 | $95.0 | +2.9% |
| 2021 | $95.0 | $67.4 | -29% |
| 2022 | $67.4 | $45.0 | -33% |
| 2023 | $45.0 | $11.1 | -75% |
| 2024 | $11.1 | $11.2 | +0.9% |
| 2025 | $11.2 | $41.9 | +274% |
| 2026 YTD | $41.9 | $56.3 | +34% |
SLGL has the edge over HIMS on returns for 2026, with the stronger performance.